Evidence map›Paper›PMID 35266249›Full record

ArticleHuman mutation2022

Tissue-specific genotype-phenotype correlations among USH2A-related disorders in the RUSH2A study.

Robert B Hufnagel, Wendi Liang, Jacque L Duncan, Carmen C Brewer, Isabelle Audo, Allison R Ayala, Kari Branham, Janet K Cheetham, Stephen P Daiger, Todd A Durham and 10 more

Open access · greenAbstract read
In one paragraph

Article in Human mutation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. ISCEV and IPS guideline for the full-field stimulus test (FST).Documenta ophthalmologica. Advances in ophthalmology · 2024
    Guideline
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. HGG advances · 2023
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 12 institutions in 4 countries.

Robert B HufnagelOphthalmic Genetics and Visual Function Branch, National Eye Institute, Bethesda, Maryland, USA.ORCID 0000-0003-3015-3545
Wendi LiangFoundation Fighting Blindness Consortium Coordinating Center, Jaeb Center for Health Research, Tampa, Florida, USA.
Jacque L DuncanDepartment of Ophthalmology, University of California, San Francisco, San Francisco, California, USA.
Carmen C BrewerOtolaryngology Branch, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, USA.
Isabelle AudoInstitut de la Vision, Sorbonne Université, INSERM, CNRS, Paris, France.ORCID 0000-0003-0698-5309
Allison R AyalaFoundation Fighting Blindness Consortium Coordinating Center, Jaeb Center for Health Research, Tampa, Florida, USA.ORCID 0000-0002-1483-7536
Kari BranhamDepartment of Ophthalmology and Vision Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA.
Janet K CheethamFoundation Fighting Blindness, Columbia, Maryland, USA.
Stephen P DaigerHealth Science Center, The University of Texas, Houston, Texas, USA.
Todd A DurhamFoundation Fighting Blindness, Columbia, Maryland, USA.
Bin GuanOphthalmic Genetics and Visual Function Branch, National Eye Institute, Bethesda, Maryland, USA.
Elise HeonDepartments of Ophthalmology and Vision Sciences, The Hospital for Sick Children, The University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0003-4143-9311
Carel B HoyngDepartment of Ophthalmology, Nijmegen, Netherlands.
Alessandro IannacconeDepartment of Ophthalmology, Duke Eye Center, Duke University Medical School, Durham, North Carolina, USA.
Christine N KayVitreoretinal Associates, Gainesville, Florida, USA.
Michel MichaelidesMoorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK.
Mark E PennesiPaul H. Casey Ophthalmic Genetics Division, Casey Eye Institute - Oregon Health and Science University, Portland, Oregon, USA.
Mandeep S SinghWilmer Eye Institute, John Hopkins University, Baltimore, Maryland, USA.
Ehsan UllahOphthalmic Genetics and Visual Function Branch, National Eye Institute, Bethesda, Maryland, USA.
Foundation Fighting Blindness Consortium Investigator Group
Foundation Fighting Blindness · USNational Eye Institute · USCentre National de la Recherche Scientifique · FRDuke University · USMoorfields Eye Hospital · GBNational Institutes of Health · USOregon Health & Science University · USRetina Vitreous Associates of Florida · USThe University of Texas Health Science Center at Houston · USUniversity of California, San Francisco · USUniversity of Michigan · USUniversity of Toronto · CA

Funding

Clinical Analysis Of Disorders Of Hearing And BalanceZIADC000064 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI HERTZANO, RONNA · 2009 to 2025
$25.2M
Rapid-Prototyping and Design CoreP30EY002162 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LAMBA, DEEPAK ASHOK · 1985 to 2024
$16.8M
Genomic and epigenomic mechanisms of pediatric ocular disordersZIAEY000565 · NEI · NATIONAL EYE INSTITUTE · PI HUFNAGEL, ROBERT · 2019 to 2024
$11.4M
Clinical ophthalmic molecular diagnostics and discoveryZIAEY000564 · NEI · NATIONAL EYE INSTITUTE · PI GUAN, BIN · 2019 to 2025
$7.9M
Speech Perception and Spoken Word Recognition by Children with Cochlear ImplantsR01DC000064 · NIDCD · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI MIYAMOTO, RICHARD T. · 1990 to 2008
$4.4M
Clinical Analysis Of Disorders Of Hearing And BalanceZ01DC000064 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI GRIFFITH, ANDREW J · 2001 to 2008
$1.2M
Foundation Fighting Blindness RUSH2A - CONSORTIUM - 2016Intramural NIH HHS Z01 DC000064Intramural NIH HHS ZIA EY000564Intramural NIH HHS ZIA EY000565NEI NIH HHS P30 EY002162NIDCD NIH HHS R01 DC000064
6 · The paper itself

Abstract

We assessed genotype-phenotype correlations among the visual, auditory, and olfactory phenotypes of 127 participants with Usher syndrome (USH2) (n =80) or nonsyndromic autosomal recessive retinitis pigmentosa (ARRP) (n = 47) due to USH2A variants, using clinical data and molecular diagnostics from the Rate of Progression in USH2A Related Retinal Degeneration (RUSH2A) study. USH2A truncating alleles were associated with USH2 and had a dose-dependent effect on hearing loss severity with no effect on visual loss severity within the USH2 subgroup. A group of missense alleles in an interfibronectin domain appeared to be hypomorphic in ARRP. These alleles were associated with later age of onset, larger visual field area, better sensitivity thresholds, and better electroretinographic responses. No effect of genotype on the severity of olfactory deficits was observed. This study unveils a unique, tissue-specific USH2A allelic hierarchy with important prognostic implications for patient counseling and treatment trial endpoints. These findings may inform clinical care or research approaches in others with allelic disorders or pleiotropic phenotypes.

Indexed as

Retinitis PigmentosaUsher SyndromesExtracellular Matrix ProteinsGenetic Association StudiesHumansMutationExtracellular Matrix ProteinsUSH2A protein, humangenotypehearing lossphotoreceptor degenerationretinitis pigmentosaUSH2AUsher syndrome

Identifiers

PMID35266249
PMCPMC9018588
OpenAlexW4220887987

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.